NL8202500A - Capsules die moederkoorn-alkaloiden bevatten, en werkwijze voor de bereiding daarvan. - Google Patents

Capsules die moederkoorn-alkaloiden bevatten, en werkwijze voor de bereiding daarvan. Download PDF

Info

Publication number
NL8202500A
NL8202500A NL8202500A NL8202500A NL8202500A NL 8202500 A NL8202500 A NL 8202500A NL 8202500 A NL8202500 A NL 8202500A NL 8202500 A NL8202500 A NL 8202500A NL 8202500 A NL8202500 A NL 8202500A
Authority
NL
Netherlands
Prior art keywords
filling
soft gelatin
ergot alkaloid
capsule
gelatin capsules
Prior art date
Application number
NL8202500A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8202500A publication Critical patent/NL8202500A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21C—PROCESSING OF PIG-IRON, e.g. REFINING, MANUFACTURE OF WROUGHT-IRON OR STEEL; TREATMENT IN MOLTEN STATE OF FERROUS ALLOYS
    • C21C7/00—Treating molten ferrous alloys, e.g. steel, not covered by groups C21C1/00 - C21C5/00
    • C21C7/0006—Adding metallic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B1/00—Preliminary treatment of ores or scrap
    • C22B1/14—Agglomerating; Briquetting; Binding; Granulating
    • C22B1/24—Binding; Briquetting ; Granulating
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B1/00—Preliminary treatment of ores or scrap
    • C22B1/14—Agglomerating; Briquetting; Binding; Granulating
    • C22B1/24—Binding; Briquetting ; Granulating
    • C22B1/248—Binding; Briquetting ; Granulating of metal scrap or alloys

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Environmental & Geological Engineering (AREA)
  • Geology (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8202500A 1981-06-24 1982-06-21 Capsules die moederkoorn-alkaloiden bevatten, en werkwijze voor de bereiding daarvan. NL8202500A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/277,980 US4366145A (en) 1981-06-24 1981-06-24 Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US27798081 1981-06-24

Publications (1)

Publication Number Publication Date
NL8202500A true NL8202500A (nl) 1983-01-17

Family

ID=23063180

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8202500A NL8202500A (nl) 1981-06-24 1982-06-21 Capsules die moederkoorn-alkaloiden bevatten, en werkwijze voor de bereiding daarvan.

Country Status (29)

Country Link
US (1) US4366145A (pt)
JP (1) JPS584716A (pt)
AT (2) AT377533B (pt)
AU (1) AU561334B2 (pt)
BE (1) BE893542A (pt)
CA (1) CA1191788A (pt)
CH (1) CH655848A5 (pt)
CY (1) CY1430A (pt)
DE (1) DE3222250A1 (pt)
DK (1) DK280282A (pt)
ES (1) ES8402504A1 (pt)
FI (1) FI80591C (pt)
FR (1) FR2508313B1 (pt)
GB (1) GB2100697B (pt)
GR (1) GR75952B (pt)
HK (1) HK53188A (pt)
HU (1) HU190393B (pt)
IE (1) IE53544B1 (pt)
IL (1) IL66113A (pt)
IT (1) IT1189289B (pt)
KE (1) KE3814A (pt)
MY (1) MY8600312A (pt)
NL (1) NL8202500A (pt)
NZ (1) NZ201046A (pt)
PH (1) PH22060A (pt)
PT (1) PT75100B (pt)
SE (1) SE455161B (pt)
SG (1) SG21388G (pt)
ZA (1) ZA824513B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
DE3413955A1 (de) * 1983-04-22 1984-10-25 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten
US4832952A (en) * 1983-07-07 1989-05-23 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
ZA845180B (en) * 1983-07-07 1986-02-26 American Home Prod Pharmaceutical composition containing a liquid lubricant
US4929640A (en) * 1988-04-04 1990-05-29 George D. McAdory Medicaments intended for combined use in the improvement of lymphocyte function
US5001117A (en) * 1989-03-07 1991-03-19 Pharmacaps, Inc. Use of lecithin to restore olfaction and taste
JPH02287913A (ja) * 1989-04-27 1990-11-28 Nec Corp トラッキング検査装置
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
US20050152969A1 (en) * 2004-01-08 2005-07-14 Chiprich Timothy B. Colored liquid-filled soft capsules and method of manufacture thereof
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE255481C (pt) *
AT164487B (de) * 1938-02-10 1949-11-10 Climax Molybdenum Co Verfahren zur Herstellung von molybdänhaltigen Eisenlegierungen und hiezu geeignetes Legierungsmittel
US2269145A (en) * 1939-06-16 1942-01-06 Upjohn Co Stabilized ergot alkaloid preparation
US2576763A (en) * 1950-03-22 1951-11-27 Climax Molybdenum Co Vanadium containing briquettes
US2870062A (en) * 1956-04-27 1959-01-20 Scherer Corp R P Gelatin composition for capsules
DE1802666B1 (de) * 1968-10-11 1970-08-27 Elektrometallurgie Gmbh Chromhaltiges Legierungsmittel fuer Metallschmelzen
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
DE2156795C3 (de) * 1970-11-20 1980-09-25 Ugine Kuhlmann Verfahren zur Herstellung von porösen Molybdänbriketts
SU432703A3 (pt) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
FR2184460B1 (pt) * 1972-05-17 1975-06-20 Fabre Sa Pierre
US3849562A (en) * 1973-03-15 1974-11-19 Sandoz Ltd Method of treating nephrosis
GB1472255A (en) * 1973-06-15 1977-05-04 Murex Ltd Additive for steel baths
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
LU71894A1 (pt) * 1974-02-22 1975-12-09
AT366576B (de) * 1974-02-22 1982-04-26 Wellcome Found Verfahren zur herstellung von pharmazeutischen praeparaten
DE2528257C2 (de) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
US4078065A (en) * 1974-07-04 1978-03-07 Sandoz Ltd. Organic compounds
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
GB2022144A (en) * 1978-06-02 1979-12-12 Cabot Corp Molybdenum additives and methods of producing same
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider

Also Published As

Publication number Publication date
ATA151282A (de) 1984-08-15
NZ201046A (en) 1986-02-21
FR2508313A1 (fr) 1982-12-31
IE53544B1 (en) 1988-12-07
JPS584716A (ja) 1983-01-11
FR2508313B1 (fr) 1986-03-21
JPH0255405B2 (pt) 1990-11-27
SE8203874D0 (sv) 1982-06-22
CA1191788A (en) 1985-08-13
US4366145A (en) 1982-12-28
PT75100A (en) 1982-07-01
IL66113A (en) 1987-02-27
FI80591C (fi) 1990-07-10
HK53188A (en) 1988-07-22
GR75952B (pt) 1984-08-02
IT1189289B (it) 1988-02-04
SG21388G (en) 1988-07-08
DE3222250C2 (pt) 1992-04-09
BE893542A (fr) 1982-12-17
HU190393B (en) 1986-08-28
DE3222250A1 (de) 1983-01-13
AU561334B2 (en) 1987-05-07
ES513359A0 (es) 1984-02-01
CY1430A (en) 1988-09-02
IE821489L (en) 1982-12-24
PH22060A (en) 1988-05-20
AT377533B (de) 1985-03-25
MY8600312A (en) 1986-12-31
PT75100B (en) 1985-01-07
ES8402504A1 (es) 1984-02-01
AT383492B (de) 1987-07-10
IL66113A0 (en) 1982-09-30
SE455161B (sv) 1988-06-27
AU8516282A (en) 1983-01-06
ATA242282A (de) 1986-12-15
GB2100697B (en) 1985-07-03
FI822187A0 (fi) 1982-06-17
KE3814A (en) 1988-08-05
ZA824513B (en) 1984-02-29
FI822187L (fi) 1982-12-25
DK280282A (da) 1982-12-25
CH655848A5 (de) 1986-05-30
GB2100697A (en) 1983-01-06
FI80591B (fi) 1990-03-30
SE8203874L (sv) 1982-12-25
IT8248677A0 (it) 1982-06-21

Similar Documents

Publication Publication Date Title
NL8202500A (nl) Capsules die moederkoorn-alkaloiden bevatten, en werkwijze voor de bereiding daarvan.
US4321253A (en) Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
JP4308902B2 (ja) 増大したバイオアベイラビリティーを有する抗真菌組成物
US4689233A (en) Coronary therapeutic agent in the form of soft gelatin capsules
JPH06695B2 (ja) 軟質ゼラチン薬剤カプセル
JP2002516860A (ja) 安定化剤としてアミノポリカルボン酸を含有する安定化抗ヒスタミンシロップ
JPS62114911A (ja) 経口投与型徐放性医薬製剤
BRPI0822206B1 (pt) Formulação líquida para deferiprona com um sabor agradável.
US6251427B1 (en) Pharmaceutical capsule compositions containing loratadine and psuedoephedrine
HU195421B (en) Process for producing melted antihistamine compositions
JPH02115126A (ja) エトポシド溶液
US7029698B2 (en) Acetaminophen compositions
KR0133517B1 (ko) 에토포시드제제
JPS6334123B2 (pt)
CS199202B2 (en) Method of producing gelatine capsules to be bitten up
JP2007514778A5 (pt)
JPS62501075A (ja) 軟ゼラチンカプセル及びその製造方法
EP3579880B1 (en) Soft gelatin capsules containing hydroxypropyl beta cyclodextrin with high stability
JPH0611696B2 (ja) ゼラチン皮膜組成物
US3077435A (en) Therapeutic composition comprising 4-(2-dimethylaminoethoxy)-4-(3, 4, 5-trimethoxybenzoyl)-benzylamine and betapyridylcarbinol
WO2020074463A1 (en) Oral liquid composition comprising triptan
WO2024132080A1 (en) Liquid pharmaceutical composition containing flecainide and process for the preparaton thereof
JPH05229947A (ja) 塩酸アゼラスチン軟カプセル剤
JPS6334125B2 (pt)

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
BC A request for examination has been filed
BV The patent application has lapsed